Full-Body AI Ultrasound Imaging Market : Global Industry Analysis and Opportunity Assessment, 2036

How big is the full-body AI ultrasound imaging market in 2026?

USD 220.0 million in 2026 and USD 897.8 million by 2036 at a 15.1% CAGR.

The full-body AI ultrasound imaging market is expected to rise from USD 191.1 million in 2025 to USD 897.8 million by 2036. Demand is expected to be driven by guided acquisition and repeatable scan review. Hospitals also need automated measurements across emergency and outpatient workflows. Handheld systems are projected to hold 67.0% share in 2026 due to low-footprint bedside use.

Market Signal	Commercial Impact
Demand and Growth Drivers	Demand for full-body AI ultrasound imaging systems is increasing as healthcare providers expand point-of-care and whole-body screening to enable faster assessments across multiple organ systems. Adoption is driven by AI-assisted image interpretation, reducing operator dependency and supporting more consistent diagnostic output across radiology and emergency care settings. Hospital network standardization and outpatient imaging expansion support sales growth as scalable ultrasound platforms provide cost advantages over CT and MRI for routine examinations. Workflow efficiency requirements and staffing shortages encourage procurement of AI-enabled ultrasound systems that shorten examination times and improve patient throughput. Growing emphasis on preventive healthcare and rapid bedside diagnostics continues to strengthen demand for AI-guided ultrasound imaging solutions.
Product and Segment View	AI algorithms, diagnostics, hospitals, and handheld systems lead their respective market segments. AI Algorithms are projected to account for 47.0% of market revenue (by technology), supported by demand for automated measurements and scan-quality scoring. Diagnostics is expected to represent 45.0% of market revenue (by application), driven by increasing ultrasound use during acute clinical assessment. Hospitals are anticipated to hold 54.0% of market revenue (by end user), supported by credentialing requirements and quality-control standards. Handheld systems are projected to record 67.0% of market revenue (by device type), reflecting strong demand for compact point-of-care imaging equipment.
Geography and Growth Outlook	North America remains a leading market while Asia continues to record rapid adoption of AI-enabled ultrasound technologies. The United States is projected to expand at 15.7% CAGR through 2036, supported by increasing availability of FDA-cleared AI ultrasound devices. China and India are expected to grow faster than the global average as healthcare access expands and cost-efficient imaging becomes a priority. Rising investments in preventive healthcare, emergency medicine, and portable imaging continue to strengthen regional demand for AI-guided ultrasound platforms.
Competitive Landscape	Competition increasingly focuses on AI capability, workflow integration, and enterprise imaging support. Butterfly Network and GE HealthCare maintain strong positions through AI-enabled ultrasound platforms, while Philips and Exo strengthen enterprise and handheld imaging portfolios. Specialist companies differentiate themselves through workflow automation, while diversified imaging vendors leverage enterprise contracts and integrated healthcare ecosystems.
Analyst Perspective	Full-body AI ultrasound imaging is becoming an important component of modern diagnostic workflows as healthcare providers seek faster imaging, standardized examinations, and improved clinical efficiency. Hospitals increasingly prioritize scan-guidance software that helps clinicians capture consistent diagnostic-quality images. Portable AI-enabled ultrasound systems reduce referral delays while expanding access to bedside and outpatient imaging. Suppliers offering FDA-cleared AI capabilities, physician training, and strong local support are expected to strengthen long-term customer relationships. - Anurag Sharma, Principal Analyst at Future Market Insights

Full-body AI ultrasound imaging demand is being shaped by the need to widen access to internal imaging without adding more pressure on specialist scanning teams. The U.S. Bureau of Labor Statistics projects diagnostic medical sonographer employment to rise 13% from 2024 to 2034 and lists about 5,800 openings each year. This workforce signal is important because AI-assisted scanning and automated image capture become more attractive when providers need repeatable exams outside radiology-led settings. Butterfly Network’s June 2026 Midjourney scanner commentary adds a different supplier signal, with the prototype using 40 Ultrasound-on-Chip imaging modules per system under a co-development agreement. Buyers are anticipated to move cautiously because full-body ultrasound platforms must prove image quality and regulatory readiness before wellness scanning can turn into broader diagnostic procurement.

Which factors support expansion in the full-body AI ultrasound imaging market?

Finished device revenue and AI software subscriptions support market value. Clinical training and scan-review services add regulated service revenue.

• Handheld probe sales support first purchase value before software subscriptions add recurring revenue.
• Supplier pricing reflects anatomy coverage and AI guidance depth before service contracts affect retention.
• Demand improves when non-specialist clinicians can capture reviewable images under supervised workflows.
• Buyer trust rises when vendors document cybersecurity controls and post-market device evidence.

Why is the full-body AI ultrasound imaging market growing?

Hospitals are testing AI-guided ultrasound due to difficulty scaling expert-dependent scanning. Emergency teams need bedside cardiac and lung views before moving patients into higher-cost imaging queues.

Point-of-care demand is no longer about image capture alone. GE HealthCare launched Caption AI on Vscan Air SL in April 2024 with real-time guidance and automated ejection fraction estimation. The product direction supports AI use when a trained operator is not a specialist sonographer.

Preventive screening is another route when private clinics need low-radiation tools that can be repeated across members. Ultrasound avoids ionizing radiation and can support bedside use. Suppliers are expected to get pricing power when handheld imaging is paired with repeatable organ coverage and physician review.

How is the full-body AI ultrasound imaging market segmented?

The market is segmented by technology, application, end user, and modality.

• AI Algorithms are projected to account for 47.0% share in 2026 due to automated view guidance becoming the main purchase trigger.
• Diagnostics is expected to represent 45.0% share in 2026 with acute-care teams using ultrasound before CT escalation.
• Hospitals are anticipated to lead with 54.0% share in 2026 led by credentialing and clinical governance.
• Handheld systems are forecast to hold 67.0% share in 2026 due to fit with ward and clinic use.
• North America is projected to account for 39.0% share in 2026 due to FDA-cleared AI ultrasound activity.

Why do AI algorithms lead the full-body AI ultrasound imaging market?

• AI Algorithms are projected to account for 47.0% share in 2026 due to buyer focus on view guidance and auto-measurement.
• Algorithm buyers compare labeled use cases and validation depth. Weak evidence can block enterprise rollout.

Which application leads the full-body AI ultrasound imaging market?

• Diagnostics is expected to represent 45.0% share in 2026 with emergency and outpatient teams using ultrasound for first-line assessment.
• Diagnostic workflows need physician review and audit trails, which makes regulated software support more important than consumer screening claims.

Which end user leads the full-body AI ultrasound imaging market?

• Hospitals are anticipated to hold 54.0% share in 2026 with governance teams managing credentialing and data storage.
• Hospital buyers favor vendors with training and service contracts. Smaller clinics compare subscription costs and image-review support.

Which modality leads the full-body AI ultrasound imaging market?

• Handheld systems are projected to account for 67.0% share in 2026 with compact probes entering emergency bays and community clinics.
• Handheld adoption depends on battery life and cleaning workflow. Tablet fit and network security affect wider use.

What is driving the full-body AI ultrasound imaging market and what is holding it back?

Scan-quality feedback and semiconductor probes support adoption. Reimbursement uncertainty limits broad asymptomatic screening.

• Driver: Scan-quality feedback is expected to support adoption by helping clinicians confirm that captured views meet diagnostic review standards.
• Driver: Semiconductor probes support broad anatomy coverage by reducing the need for multiple probe purchases.
• Restraint: Whole-body screening faces restraint from physician review capacity and uncertain reimbursement for asymptomatic users.
• Opportunity: Tomographic reconstruction can support premium workflows that need volumetric data without CT radiation exposure.
• Opportunity: Cloud-connected workflow tools can support networked clinics when cybersecurity and patient-data rules are handled clearly.

Guided Scan Demand Outlook in the Full-Body AI Ultrasound Imaging Market

Demand outlook is shifting toward guided scanning that can prove scan consistency before wider screening use. FDA issued final PCCP guidance for AI-enabled device software in August 2025. The guidance gives vendors a clearer route to document planned software changes. Hospital committees can use that evidence before approving wider clinical use.

Operator support has become a clearer buying point now that ultrasound AI is moving into multiple care settings. GE HealthCare agreed in July 2024 to acquire Intelligent Ultrasound’s clinical AI software business for about USD 51 million. The deal added real-time image recognition support for OB/GYN scans. Hospitals are expected to value tools that reduce repeat work and keep image review consistent.

Hospital Buyer Segmentation and Purchase Behavior Analysis

Hospitals form the main buyer group due to their ability to manage credentialing and escalation. Clinics form the second buying route when compact devices reduce referral delays. Butterfly launched Compass AI in November 2025 to manage compliant POCUS programs. This supports health system buyers that want guided imaging without fragmented reporting.

Clinical Workflow and Decision-driver Analysis

Purchase decisions are shaped by scan coverage and AI guidance accuracy. Service support and data governance shape final approval. Exo added a HFpEF and cardiotoxicity indicator to Exo Iris in April 2025. The update shows why buyers compare clinical use cases before they compare probe price.

Which countries are growing fastest in the full-body AI ultrasound imaging market?

India 17.2% CAGR, China 16.8% CAGR, United States 15.7% CAGR, South Korea 15.4% CAGR, followed by the United Kingdom and Japan, with Germany and France through 2036.

Country	CAGR
India	17.2%
China	16.8%
United States	15.7%
South Korea	15.4%
United Kingdom	14.8%
Japan	14.5%
Germany	14.1%
France	13.8%

Source: Future Market Insights, 2026.

How do country-level CAGRs compare in the full-body AI ultrasound imaging market?

• India is forecast to record 17.2% CAGR by 2036 with urban diagnostic access and private chains favoring handheld platforms.
• China is expected to expand at 16.8% CAGR by 2036 due to domestic vendor capacity and maternal-care imaging demand.
• The United States is projected to grow at 15.7% CAGR due to FDA-cleared device depth and early hospital rollouts.
• South Korea is estimated to rise at 15.4% CAGR with premium hospitals and local ultrasound suppliers supporting AI pilots.
• The United Kingdom is forecast to grow at 14.8% CAGR supported by community diagnostics and new placement points.
• Japan is expected to advance at 14.5% CAGR due to ageing-care needs and bedside ultrasound workflows.
• Germany and France are projected to grow below the fastest markets due to cautious procurement review.

How fast is the full-body AI ultrasound imaging market growing in India?

A 17.2% CAGR through 2036 reflects local imaging demand and readiness for AI-guided ultrasound workflows.

Country Market Snapshot Table

Parameter	Value
Market Size in 2025 (Value)	USD 7.3 million
Market Size in 2026 (Value)	USD 8.5 million
Market Forecast in 2036 (Value)	USD 41.6 million
CAGR (2026 to 2036)	17.2%
Years Considered	2021 to 2036
Base Year	2025
Forecast Period	2026 to 2036
Units Considered	Value (USD million)
Leading Sub-Region	Delhi NCR, Mumbai, Bengaluru, Hyderabad, Chennai, and Pune

India Full-Body AI Ultrasound Imaging Market Outlook

India demand is shaped by diagnostic access gaps and the need for lower-footprint imaging in urban and semi-urban care networks. Private hospital groups and diagnostic chains are expected to test guided ultrasound where conventional imaging queues remain long.

Adoption is expected to be strongest where vendors combine handheld devices with training and service support. Physician review workflows remain important. Price discipline remains central when buyers compare software subscriptions against capital budgets.

Key Growth Drivers

• Urban care networks can support portable guided scanning. MoHFW reported 1,373 functional polyclinics in September 2025.
• Public primary-care sites create a wider access route. PIB reported 180,906 Ayushman Arogya Mandirs operational in October 2025.
• Hospital networks can test guided scans at scale. PIB reported over 33,000 hospitals empanelled under AB-PMJAY in November 2025.
• Private diagnostic chains can scale standardized scan protocols in cities where physician review is available.

Key Restraints

• Specialist availability can slow supervised adoption. MoHFW reported 407 specialists in position under NUHM in January 2026.
• Premium scanner pricing limits uptake outside major hospitals and high-volume diagnostic centers.
• Training gaps and compliance oversight can slow use by first-time operators.

What makes India unique

India stands out for access gaps that create demand for guided imaging beyond tertiary hospitals.

Key Companies

• GE HealthCare India
• Philips India
• Samsung Medison India
• FUJIFILM Sonosite India
• Trivitron Healthcare
• Mindray India
• Butterfly Network distribution partners

Sales & Marketing Channels

• Private hospital groups
• Diagnostic chains
• Public health tenders
• Medical device distributors
• Emergency-care departments
• Telehealth review networks

Country Segment Breakdown Table

Segment	Sub-Segments
By Technology	Ultrasound-on-Chip · AI Algorithms · Tomographic Reconstruction
By Application	Preventive Health · Diagnostics · Screening
By End User	Hospitals · Clinics · Direct-to-Consumer
By Modality	Handheld · Whole-Body Scanner
Key Sub-Regions Covered	Delhi NCR · Mumbai · Bengaluru · Hyderabad · Chennai · Pune

Frequently Asked Questions

How fast is India full-body AI ultrasound imaging market growing?

Sales in India are projected to rise at 17.2% CAGR from 2026 to 2036.

Who leads India full-body AI ultrasound imaging market?

GE HealthCare India and Philips India compete through ultrasound systems and service support. Samsung Medison India and FUJIFILM Sonosite India add AI workflow evidence.

What is driving adoption in India full-body AI ultrasound imaging market?

Guided scanning and portable placement are expected to support adoption. Physician-reviewed workflows remain needed for wider use.

How fast is the full-body AI ultrasound imaging market growing in China?

A 16.8% CAGR through 2036 reflects local imaging demand and readiness for AI-guided ultrasound workflows.

Country Market Snapshot Table

Parameter	Value
Market Size in 2025 (Value)	USD 25.7 million
Market Size in 2026 (Value)	USD 30.0 million
Market Forecast in 2036 (Value)	USD 141.8 million
CAGR (2026 to 2036)	16.8%
Years Considered	2021 to 2036
Base Year	2025
Forecast Period	2026 to 2036
Units Considered	Value (USD million)
Leading Sub-Region	Shanghai, Beijing, Guangdong, Jiangsu, Zhejiang, and Sichuan

China Full-Body AI Ultrasound Imaging Market Outlook

China demand is backed by large hospital networks and domestic imaging vendor capacity. Guided ultrasound can fit hospital workflows when software is localized for Chinese clinical pathways.

Procurement remains price-sensitive when provincial tenders compress margins. Vendors need registration support and local service networks before broad rollout.

Key Growth Drivers

• Hospital network depth can support guided ultrasound rollout. NBS reported 38 thousand hospitals in China by the end of 2025.
• Maternal and pediatric networks support portable ultrasound access. NBS reported 3,073 maternity and child care institutions in 2024.
• Domestic imaging vendors can pair hardware production with software localization for hospital tenders.
• Primary care and maternal health programs can use guided scanning when specialist access is thinner.

Key Restraints

• Population decline can temper future screening volume. NBS reported 7.92 million births in 2025.
• Provincial procurement can place heavy pressure on pricing and service commitments.
• Foreign vendors face registration and localization requirements before reaching broad tender access.

What makes China unique

China stands out for domestic manufacturing and large care networks that can scale AI ultrasound after registration hurdles are cleared.

Key Companies

• Mindray
• SonoScape
• Wisonic
• GE HealthCare China
• Philips China
• Samsung Medison China
• Beijing Infervision Healthcare Medical Technology

Sales & Marketing Channels

• Provincial tenders
• Public hospitals
• Maternal-care networks
• Private hospital groups
• Device distributors
• Primary-care pilots

Country Segment Breakdown Table

Segment	Sub-Segments
By Technology	Ultrasound-on-Chip · AI Algorithms · Tomographic Reconstruction
By Application	Preventive Health · Diagnostics · Screening
By End User	Hospitals · Clinics · Direct-to-Consumer
By Modality	Handheld · Whole-Body Scanner
Key Sub-Regions Covered	Shanghai · Beijing · Guangdong · Jiangsu · Zhejiang · Sichuan

Frequently Asked Questions

How fast is China full-body AI ultrasound imaging market growing?

Sales in China are projected to rise at 16.8% CAGR from 2026 to 2036.

Who leads China full-body AI ultrasound imaging market?

Mindray and SonoScape compete through local ultrasound platforms. Wisonic and GE HealthCare China add service support and AI workflow evidence.

What is driving adoption in China full-body AI ultrasound imaging market?

Guided scanning and portable placement are expected to support adoption. Physician-reviewed workflows remain needed for wider use.

How fast is the full-body AI ultrasound imaging market growing in United States?

A 15.7% CAGR through 2036 reflects local imaging demand and readiness for AI-guided ultrasound workflows.

Country Market Snapshot Table

Parameter	Value
Market Size in 2025 (Value)	USD 38.0 million
Market Size in 2026 (Value)	USD 44.0 million
Market Forecast in 2036 (Value)	USD 189.1 million
CAGR (2026 to 2036)	15.7%
Years Considered	2021 to 2036
Base Year	2025
Forecast Period	2026 to 2036
Units Considered	Value (USD million)
Leading Sub-Region	California, Massachusetts, Texas, New York, Florida, and Midwest hospital systems

United States Full-Body AI Ultrasound Imaging Market Outlook

United States demand is led by FDA-cleared AI ultrasound products and early hospital innovation budgets. Hospitals are using guided scanning for emergency and cardiac workflows before wider full-body protocols. Lung and women’s health use cases add further routes.

Commercial adoption depends on clinical governance and cybersecurity review. Buyers give preference to suppliers that can document clearance status and service training. Enterprise data controls also affect approval.

Key Growth Drivers

• FDA-cleared AI availability reduces hospital review friction. FDA stated in January 2025 that it had authorized over 1,000 AI-enabled devices.
• Emergency departments need faster bedside triage. CDC reported 155.4 million U.S. emergency department visits in its latest FastStats release.
• Enterprise hospital systems can test AI guidance across emergency and cardiac workflows before larger fleet rollouts.
• Private preventive health providers can pair handheld scanning with physician review for controlled outpatient screening pilots.

Key Restraints

• Cybersecurity documentation can slow connected ultrasound rollout. HHS OCR investigates breaches affecting 500 or more individuals.
• Credentialing requirements are expected to limit unsupervised scanning by new users until hospitals define review rules.
• Payer coverage for broad preventive ultrasound screening is expected to remain selective due to follow-up capacity needs.

What makes United States unique

The United States stands out for FDA clearance data that gives buyers a transparent route to compare AI ultrasound claims.

Key Companies

• Butterfly Network
• GE HealthCare
• Philips Ultrasound
• Exo
• Clarius Mobile Health
• EchoNous
• FUJIFILM Sonosite

Sales & Marketing Channels

• Integrated delivery networks
• Emergency departments
• Imaging departments
• Private preventive clinics
• Medical device distributors
• Employer health providers

Country Segment Breakdown Table

Segment	Sub-Segments
By Technology	Ultrasound-on-Chip · AI Algorithms · Tomographic Reconstruction
By Application	Preventive Health · Diagnostics · Screening
By End User	Hospitals · Clinics · Direct-to-Consumer
By Modality	Handheld · Whole-Body Scanner
Key Sub-Regions Covered	California · Massachusetts · Texas · New York · Florida · Midwest hospital systems

Frequently Asked Questions

How fast is United States full-body AI ultrasound imaging market growing?

Sales in United States are projected to rise at 15.7% CAGR from 2026 to 2036.

Who leads United States full-body AI ultrasound imaging market?

Butterfly Network and GE HealthCare compete through clearance evidence. Philips Ultrasound and Exo add enterprise service and AI workflow support.

What is driving adoption in United States full-body AI ultrasound imaging market?

Guided scanning and portable placement are expected to support adoption. Physician-reviewed workflows remain needed for wider use.

How fast is the full-body AI ultrasound imaging market growing in South Korea?

A 15.4% CAGR through 2036 reflects local imaging demand and readiness for AI-guided ultrasound workflows.

Country Market Snapshot Table

Parameter	Value
Market Size in 2025 (Value)	USD 8.8 million
Market Size in 2026 (Value)	USD 10.2 million
Market Forecast in 2036 (Value)	USD 42.7 million
CAGR (2026 to 2036)	15.4%
Years Considered	2021 to 2036
Base Year	2025
Forecast Period	2026 to 2036
Units Considered	Value (USD million)
Leading Sub-Region	Seoul Capital Area, Busan, Daegu, Daejeon, Gwangju, and Ulsan

South Korea Full-Body AI Ultrasound Imaging Market Outlook

South Korea demand is backed by premium hospital infrastructure and domestic ultrasound capability. Samsung Medison gives the market a local enterprise platform for AI workflow expansion.

Hospital buyers are expected to compare global AI tools against local service quality and Korean-language workflow support. Imported systems need clear clinical differentiation before broad department use.

Key Growth Drivers

• Premium hospital infrastructure supports AI tool testing. OECD reported Korea had 12.6 hospital beds per 1,000 population in 2025.
• Diagnostic equipment density supports guided imaging workflows. OECD reported Korea had 87 CT and MRI units per million population in 2025.
• Samsung Medison strengthens domestic ultrasound AI platform capability through Sonio workflow integration.
• MFDS guidance gives suppliers a clearer review route for AI-based medical devices.

Key Restraints

• Local competition remains strong. KOSTAT reported 9.50 million Koreans aged 65 or more in 2023, drawing domestic suppliers toward senior-care imaging.
• Hospital buyers may require Korean-language workflow and service support before wider department rollout.
• Imported systems need strong differentiation against Samsung’s local ultrasound platform strength.

What makes South Korea unique

South Korea stands out for local ultrasound strength and premium hospital infrastructure that support fast technical evaluation.

Key Companies

• Samsung Medison
• GE HealthCare Korea
• Philips Korea
• Mindray Korea
• SonoScape Korea
• Butterfly Network partners
• Lunit adjacent imaging AI

Sales & Marketing Channels

• University hospitals
• Private hospital groups
• Device distributors
• Senior-care networks
• Emergency departments
• Imaging centers

Country Segment Breakdown Table

Segment	Sub-Segments
By Technology	Ultrasound-on-Chip · AI Algorithms · Tomographic Reconstruction
By Application	Preventive Health · Diagnostics · Screening
By End User	Hospitals · Clinics · Direct-to-Consumer
By Modality	Handheld · Whole-Body Scanner
Key Sub-Regions Covered	Seoul · Busan · Daegu · Daejeon · Gwangju · Ulsan

Frequently Asked Questions

How fast is South Korea full-body AI ultrasound imaging market growing?

Sales in South Korea are projected to rise at 15.4% CAGR from 2026 to 2036.

Who leads South Korea full-body AI ultrasound imaging market?

Samsung Medison and GE HealthCare Korea compete through ultrasound systems. Philips Korea and Mindray Korea add service support and AI workflow evidence.

What is driving adoption in South Korea full-body AI ultrasound imaging market?

Guided scanning and portable placement are expected to support adoption. Physician-reviewed workflows remain needed for wider use.

How fast is the full-body AI ultrasound imaging market growing in United Kingdom?

A 14.8% CAGR through 2036 reflects local imaging demand and readiness for AI-guided ultrasound workflows.

Country Market Snapshot Table

Parameter	Value
Market Size in 2025 (Value)	USD 18.7 million
Market Size in 2026 (Value)	USD 21.5 million
Market Forecast in 2036 (Value)	USD 85.5 million
CAGR (2026 to 2036)	14.8%
Years Considered	2021 to 2036
Base Year	2025
Forecast Period	2026 to 2036
Units Considered	Value (USD million)
Leading Sub-Region	London, Manchester, Birmingham, Leeds, Glasgow, and community diagnostic hubs

United Kingdom Full-Body AI Ultrasound Imaging Market Outlook

United Kingdom demand is shaped by diagnostic wait pressure and the shift toward community-based testing. AI-guided ultrasound can support NHS and private providers when governance teams approve scan protocols.

Adoption depends on trust procurement and interoperability review. Suppliers with NHS-ready cybersecurity evidence and staff training programs are expected to face less rollout friction.

Key Growth Drivers

• NHS England reported 11.5 million ultrasound procedures in 2024/25, giving vendors a large diagnostic base for guided scanning.
• Government investment supports care closer to home. DHSC announced GBP 237 million for community diagnostic expansion in April 2026.
• Community Diagnostic Centres can support portable ultrasound use when trusts need lower-footprint imaging outside acute hospitals.
• Trust-level digital programs favor vendors that package audit logs and training evidence.

Key Restraints

• Capacity pressure remains high. NHS England reported 1.7 million diagnostic waits at the end of April 2025.
• Tender timelines can delay scale after successful pilots due to evidence and budget approval requirements.
• Clinical staffing pressure can limit supervision capacity for new scanning roles in community sites.

What makes United Kingdom unique

The United Kingdom stands out for community diagnostics that create structured points for portable guided ultrasound placement.

Key Companies

• GE HealthCare UK
• Philips UK
• FUJIFILM Sonosite UK
• Clarius UK partners
• Butterfly Network UK
• Samsung Medison UK
• Canon Medical Systems UK

Sales & Marketing Channels

• NHS trusts
• Community Diagnostic Centres
• Private hospitals
• Imaging service providers
• Emergency departments
• Device distributors

Country Segment Breakdown Table

Segment	Sub-Segments
By Technology	Ultrasound-on-Chip · AI Algorithms · Tomographic Reconstruction
By Application	Preventive Health · Diagnostics · Screening
By End User	Hospitals · Clinics · Direct-to-Consumer
By Modality	Handheld · Whole-Body Scanner
Key Sub-Regions Covered	London · Manchester · Birmingham · Leeds · Glasgow · Community diagnostic hubs

Frequently Asked Questions

How fast is United Kingdom full-body AI ultrasound imaging market growing?

Sales in United Kingdom are projected to rise at 14.8% CAGR from 2026 to 2036.

Who leads United Kingdom full-body AI ultrasound imaging market?

GE HealthCare UK and Philips UK compete through NHS-ready service. FUJIFILM Sonosite UK and Clarius UK partners add portable ultrasound depth.

What is driving adoption in United Kingdom full-body AI ultrasound imaging market?

Guided scanning and portable placement are expected to support adoption. Physician-reviewed workflows remain needed for wider use.

How fast is the full-body AI ultrasound imaging market growing in Japan?

A 14.5% CAGR through 2036 reflects local imaging demand and readiness for AI-guided ultrasound workflows.

Country Market Snapshot Table

Parameter	Value
Market Size in 2025 (Value)	USD 15.4 million
Market Size in 2026 (Value)	USD 17.6 million
Market Forecast in 2036 (Value)	USD 68.2 million
CAGR (2026 to 2036)	14.5%
Years Considered	2021 to 2036
Base Year	2025
Forecast Period	2026 to 2036
Units Considered	Value (USD million)
Leading Sub-Region	Tokyo, Osaka, Nagoya, Fukuoka, Sapporo, and regional acute-care networks

Japan Full-Body AI Ultrasound Imaging Market Outlook

Japan demand is shaped by ageing-care pressure and high expectations for diagnostic quality. AI-guided ultrasound can support bedside assessment when clinical evidence fits Japanese hospital workflows.

Adoption is expected to move carefully in a system with deep premium imaging capacity. Suppliers need local-language support and controlled claims to win procurement confidence.

Key Growth Drivers

• Ageing-care demand supports bedside imaging and monitoring. Japan’s Cabinet Office reported 36.24 million residents aged 65 and over in 2024.
• Premium diagnostic standards support validated imaging tools. OECD reported Japan had 184 CT and MRI units per million population in 2025.
• Preventive health culture supports careful screening use in private settings when physician review remains central.
• Japanese-language workflow support can help suppliers reduce adoption friction in hospital departments.

Key Restraints

• Approval planning stays cautious. PMDA released an AI use action plan in October 2025.
• Hospitals may avoid broad claims until local evidence confirms AI measurement consistency across Japanese clinical settings.
• Conservative purchasing behavior can slow full-body screening rollouts where premium imaging assets remain available.

What makes Japan unique

Japan stands out for ageing-care needs and premium imaging standards that support cautious AI workflow adoption.

Key Companies

• GE HealthCare Japan
• Philips Japan
• Canon Medical Systems
• Fujifilm Healthcare
• Konica Minolta Healthcare
• Samsung Medison Japan
• Butterfly Network partners

Sales & Marketing Channels

• University hospitals
• Private imaging clinics
• Senior-care providers
• Emergency departments
• Device distributors
• Preventive health clinics

Country Segment Breakdown Table

Segment	Sub-Segments
By Technology	Ultrasound-on-Chip · AI Algorithms · Tomographic Reconstruction
By Application	Preventive Health · Diagnostics · Screening
By End User	Hospitals · Clinics · Direct-to-Consumer
By Modality	Handheld · Whole-Body Scanner
Key Sub-Regions Covered	Tokyo · Osaka · Nagoya · Fukuoka · Sapporo · Regional acute-care networks

Frequently Asked Questions

How fast is Japan full-body AI ultrasound imaging market growing?

Sales in Japan are projected to rise at 14.5% CAGR from 2026 to 2036.

Who leads Japan full-body AI ultrasound imaging market?

GE HealthCare Japan and Philips Japan compete through ultrasound systems. Canon Medical Systems and Fujifilm Healthcare add local service depth.

What is driving adoption in Japan full-body AI ultrasound imaging market?

Guided scanning and portable placement are expected to support adoption. Physician-reviewed workflows remain needed for wider use.

How fast is the full-body AI ultrasound imaging market growing in Germany?

A 14.1% CAGR through 2036 reflects local imaging demand and readiness for AI-guided ultrasound workflows.

Country Market Snapshot Table

Parameter	Value
Market Size in 2025 (Value)	USD 16.5 million
Market Size in 2026 (Value)	USD 18.8 million
Market Forecast in 2036 (Value)	USD 70.3 million
CAGR (2026 to 2036)	14.1%
Years Considered	2021 to 2036
Base Year	2025
Forecast Period	2026 to 2036
Units Considered	Value (USD million)
Leading Sub-Region	North Rhine-Westphalia, Bavaria, Baden-Wurttemberg, Berlin, Hamburg, and Hesse

Germany Full-Body AI Ultrasound Imaging Market Outlook

Germany demand is shaped by specialist imaging capacity and strict procurement review. Hospitals and specialty practices are expected to adopt guided ultrasound where it reduces measurement variation without weakening physician oversight.

EU medical device and AI rules make documentation central to supplier selection. Vendors need post-market evidence and local service depth to convert pilots into department-wide use.

Key Growth Drivers

• Germany’s diagnostic base supports connected ultrasound upgrades. Eurostat reported 3,088 CT scanners in Germany in 2023.
• Specialist imaging capacity remains deep. Eurostat reported 2,940 MRI units in Germany in 2023.
• Specialist practices value AI tools that reduce manual measurement variation without weakening physician oversight.
• EU medical device and AI rules favor vendors that can show post-market evidence and controlled claims.

Key Restraints

• Budget competition remains tight across imaging assets. Eurostat reported Germany had 638,354 hospital beds in 2023.
• Data privacy review can slow cloud workflow integration where images or measurements move outside hospital networks.
• Hospital budget cycles may delay replacement of functioning ultrasound assets until service contracts expire.

What makes Germany unique

Germany stands out for strict evidence expectations that favor vendors with documented clinical and compliance support.

Key Companies

• Siemens Healthineers adjacent imaging portfolio
• GE HealthCare Germany
• Philips Germany
• Samsung Medison Germany
• FUJIFILM Sonosite Germany
• Mindray Germany
• Butterfly Network partners

Sales & Marketing Channels

• University hospitals
• Specialist practices
• Private hospital chains
• Device distributors
• Emergency departments
• Public tenders

Country Segment Breakdown Table

Segment	Sub-Segments
By Technology	Ultrasound-on-Chip · AI Algorithms · Tomographic Reconstruction
By Application	Preventive Health · Diagnostics · Screening
By End User	Hospitals · Clinics · Direct-to-Consumer
By Modality	Handheld · Whole-Body Scanner
Key Sub-Regions Covered	North Rhine-Westphalia · Bavaria · Baden-Wurttemberg · Berlin · Hamburg · Hesse

Frequently Asked Questions

How fast is Germany full-body AI ultrasound imaging market growing?

Sales in Germany are projected to rise at 14.1% CAGR from 2026 to 2036.

Who leads Germany full-body AI ultrasound imaging market?

Siemens Healthineers and GE HealthCare Germany compete through enterprise imaging access. Philips Germany and Samsung Medison Germany add ultrasound service support.

What is driving adoption in Germany full-body AI ultrasound imaging market?

Guided scanning and portable placement are expected to support adoption. Physician-reviewed workflows remain needed for wider use.

How fast is the full-body AI ultrasound imaging market growing in France?

A 13.8% CAGR through 2036 reflects local imaging demand and readiness for AI-guided ultrasound workflows.

Country Market Snapshot Table

Parameter	Value
Market Size in 2025 (Value)	USD 14.0 million
Market Size in 2026 (Value)	USD 15.9 million
Market Forecast in 2036 (Value)	USD 57.9 million
CAGR (2026 to 2036)	13.8%
Years Considered	2021 to 2036
Base Year	2025
Forecast Period	2026 to 2036
Units Considered	Value (USD million)
Leading Sub-Region	Ile-de-France, Auvergne-Rhone-Alpes, Provence-Alpes-Cote d’Azur, Occitanie, Nouvelle-Aquitaine, and Hauts-de-France

France Full-Body AI Ultrasound Imaging Market Outlook

France demand is backed by health system scale and local AI ultrasound expertise. Sonio gives France a stronger role in obstetric workflow AI.

Procurement is expected to remain cautious due to public financing pressure and clinical review requirements. Private imaging clinics may move faster when AI reduces documentation workload.

Key Growth Drivers

• Health system scale supports AI workflow trials. DREES reported French current health expenditure of EUR 332.6 billion in 2024.
• Preventive-care spending can support governed screening workflows. DREES reported preventive care expenditure rose 0.9% in 2024.
• Local ultrasound AI expertise supports obstetric and screening workflow development through Sonio and similar companies.
• Private imaging clinics can adopt faster when AI reduces documentation workload and improves exam consistency.

Key Restraints

• Public reimbursement pressure can limit broad screening. DREES reported public financing of healthcare consumption fell by 0.5 percentage points in 2024.
• Public hospital procurement can slow new platform rollout when clinical committees require staged evidence.
• Broad preventive scanning needs clearer follow-up rules when incidental findings increase specialist review.

What makes France unique

France stands out for local AI ultrasound capability that gives the country a stronger role in clinical workflow design.

Key Companies

• Sonio
• Samsung Medison France
• GE HealthCare France
• Philips France
• Fujifilm Healthcare France
• Canon Medical Systems France
• Butterfly Network partners

Sales & Marketing Channels

• Public hospitals
• Private imaging clinics
• Maternal-care networks
• Device distributors
• Emergency departments
• Preventive health clinics

Country Segment Breakdown Table

Segment	Sub-Segments
By Technology	Ultrasound-on-Chip · AI Algorithms · Tomographic Reconstruction
By Application	Preventive Health · Diagnostics · Screening
By End User	Hospitals · Clinics · Direct-to-Consumer
By Modality	Handheld · Whole-Body Scanner
Key Sub-Regions Covered	Ile-de-France · Lyon · Marseille · Toulouse · Bordeaux · Lille

Frequently Asked Questions

How fast is France full-body AI ultrasound imaging market growing?

Sales in France are projected to rise at 13.8% CAGR from 2026 to 2036.

Who leads France full-body AI ultrasound imaging market?

Sonio and Samsung Medison France compete through workflow AI. GE HealthCare France and Philips France add ultrasound service support.

What is driving adoption in France full-body AI ultrasound imaging market?

Guided scanning and portable placement are expected to support adoption. Physician-reviewed workflows remain needed for wider use.

Who are the leading companies in the full-body AI ultrasound imaging market?

Butterfly Network and GE HealthCare lead the supplier field. Philips, Exo and Samsung Medison add platform depth.

• Handheld ultrasound suppliers hold an advantage through compact probes and scan guidance.
• Enterprise imaging vendors gain buyer trust through hospital contracts and service teams.
• Workflow AI specialists stand out with measurement automation and review tools.
• Training and cybersecurity support help suppliers convert pilots into broader rollouts.

Competition in the market is built around workflow proof instead of device hardware alone. Butterfly Network holds a clear handheld position through iQ3 and whole-body probe coverage. GE HealthCare and Philips gain access through existing ultrasound relationships. Exo and Clarius compete by making point-of-care programs easier to manage.

GE HealthCare strengthened its ultrasound AI depth in July 2024 by agreeing to acquire Intelligent Ultrasound’s clinical AI business. The deal added real-time image recognition support for OB/GYN scans. This gives GE HealthCare a stronger route into guided scanning where hospitals need repeatable workflows. Butterfly added a workflow layer in November 2025 with Compass AI for POCUS program management. The platform targets documentation and quality-assurance gaps in health systems. This places Butterfly closer to enterprise software buying decisions beyond probe selection.

How do top full-body AI ultrasound imaging companies compare?

Butterfly Network scores strongest on handheld whole-body positioning. GE HealthCare and Philips lead on enterprise access and clinical service depth.

Company	Handheld Platform Depth	AI Workflow Strength	Enterprise Access	Regulatory Evidence	Geographic Footprint
Butterfly Network	Very Strong	Very Strong	Strong	Very Strong	United States and selected global markets
GE HealthCare	Strong	Very Strong	Very Strong	Very Strong	Global
Philips	Strong	Strong	Very Strong	Very Strong	Global
Exo	Very Strong	Strong	Moderate	Strong	United States and selected international markets
Samsung Medison	Strong	Strong	Strong	Strong	South Korea and global ultrasound markets
Clarius Mobile Health	Very Strong	Moderate	Moderate	Strong	North America and international distributor routes
EchoNous	Strong	Moderate	Moderate	Strong	United States and selected markets
FUJIFILM Sonosite	Strong	Moderate	Strong	Strong	Global
Mindray	Strong	Moderate	Strong	Strong	China and global hospital markets
Canon Medical Systems	Moderate	Moderate	Very Strong	Strong	Japan and global enterprise imaging markets

Source: Future Market Insights competitive analysis, 2026.

Which companies are active in the full-body AI ultrasound imaging market?

Butterfly Network and GE HealthCare are listed with Philips. Exo and Samsung Medison are among other suppliers.

Key global companies leading the full-body AI ultrasound imaging market include:

• Butterfly Network
• GE HealthCare
• Philips
• Exo
• Clarius Mobile Health
• EchoNous
• Samsung Medison
• FUJIFILM Sonosite
• Mindray
• Canon Medical Systems

Key Developments in Full-Body AI Ultrasound Imaging Market

• In January 2024, Butterfly Network received FDA clearance for Butterfly iQ3. The system supports semiconductor-based handheld ultrasound and whole-body scan coverage.
• In April 2024, GE HealthCare introduced Caption AI on Vscan Air SL. The launch added real-time cardiac guidance and automated ejection fraction support to a handheld ultrasound system.
• In June 2026, Philips received FDA 510(k) clearance for Elevate Plus for EPIQ Elite and Affiniti. The clearance added AI advancements for general imaging ultrasound workflows.

Key Players in the Full-Body AI Ultrasound Imaging Market

Handheld Ultrasound Platforms

• Butterfly Network
• Exo
• Clarius Mobile Health
• EchoNous

Enterprise Imaging Vendors

• GE HealthCare
• Philips
• Samsung Medison
• FUJIFILM Sonosite
• Canon Medical Systems

Regional and Workflow AI Companies

• Mindray
• SonoScape
• Sonio
• Lunit adjacent imaging AI

Full-Body AI Ultrasound Imaging Market - Report Scope

Parameter	Details
Forecast period	2026 to 2036
Historical period	2021 to 2025
Quantitative unit	Revenue in USD million
By technology	Ultrasound-on-Chip, AI algorithms, tomographic reconstruction
By application	Preventive health, diagnostics, screening
By end user	Hospitals, clinics, direct-to-consumer
By modality	Handheld systems, whole-body scanner
Regions covered	North America, Latin America, Europe, East Asia, South Asia and Pacific, Middle East and Africa
Countries covered	India, China, United States, South Korea, United Kingdom, Japan, Germany, France
Key companies profiled	Butterfly Network, GE HealthCare, Philips, Exo, Clarius Mobile Health, EchoNous, Samsung Medison, FUJIFILM Sonosite, Mindray, Canon Medical Systems
Approach	Bottom-up device and software revenue approach using handheld system demand, AI software attachment, scan workflow adoption, end-user readiness, regulatory clearance signals, and country-level imaging access
Source	Future Market Insights, 2026.

Full-Body AI Ultrasound Imaging Market - Scope & Definition

Parameter	Scope
Market Definition	AI-enabled ultrasound systems and software used to guide scan capture and review across multiple body areas.
Included Products	Ultrasound-on-chip probes, AI algorithms, tomographic reconstruction software, handheld systems, and whole-body scanners.
Included Applications	Preventive health, diagnostics, and screening workflows that use regulated ultrasound tools.
Included End Users	Hospitals, clinics, and direct-to-consumer providers using physician-reviewed or governed imaging workflows.
Included Modalities	Handheld systems and whole-body scanners used for compact or multi-area ultrasound imaging.
Excluded Products	Conventional non-AI ultrasound carts, MRI screening centers, CT scanners, X-ray systems, and wellness devices without diagnostic intent.
Revenue Boundary	Device revenue, software subscriptions, workflow tools, and AI-enabled ultrasound platform revenue before unrelated imaging services.
Geographic Coverage	North America, Latin America, Europe, East Asia, South Asia and Pacific, Middle East and Africa, and selected country markets.

Full-Body AI Ultrasound Imaging Market - Research Methodology

Research Step	Method Used
Primary Research	Interviews reviewed hospital imaging needs, emergency-care use, private clinic plans, distributor feedback, and buyer expectations for guided scanning.
Desk Research	Regulator lists, product clearances, company disclosures, health-system statistics, and device cybersecurity guidance were reviewed.
Market Sizing	Device shipments, software attachment, subscription pricing, technology mix, modality demand, and country readiness were combined.
Forecasting	Growth projections used hospital adoption patterns, handheld system penetration, AI clearance activity, imaging access gaps, and end-user workflow demand.
Data Validation	Estimates were compared with ultrasound device activity, medical imaging software adoption, AI-enabled medical device lists, and company launch evidence.
Quality Control	Source verification, duplicate statistic review, segmentation consistency checks, and reference-format alignment were completed before final table preparation.

Full-Body AI Ultrasound Imaging Market Breakdown by Technology, Application, End User, Modality, and Region

Full-Body AI Ultrasound Imaging Market Segmented by Technology:

• Ultrasound-on-Chip
• AI Algorithms
• Tomographic Reconstruction

Full-Body AI Ultrasound Imaging Market Segmented by Application:

• Preventive Health
• Diagnostics
• Screening

Full-Body AI Ultrasound Imaging Market Segmented by End User:

• Hospitals
• Clinics
• Direct-to-Consumer

Full-Body AI Ultrasound Imaging Market Segmented by Modality:

• Handheld Systems
• Whole-Body Scanner

Full-Body AI Ultrasound Imaging Market by Region:

• North America
• Latin America
• Europe
• East Asia
• South Asia and Pacific
• Middle East and Africa

Research Sources and Bibliography

• U.S. Food and Drug Administration. (2026, June). Artificial intelligence-enabled medical devices.
• U.S. Food and Drug Administration. (2025, January 6). FDA issues comprehensive draft guidance for developers of artificial intelligence-enabled medical devices.
• U.S. Food and Drug Administration. (2026, February 3). Cybersecurity in medical devices: Quality system considerations and content of premarket submissions.
• Centers for Disease Control and Prevention. (2024, August). Emergency department visit rates by selected characteristics: United States, 2022.
• U.S. Department of Health and Human Services Office for Civil Rights. (2026). Breach portal: Notice to the Secretary of HHS breach of unsecured protected health information.
• NHS England. (2025, November 27). Diagnostic Imaging Dataset annual statistical release 2024/25.
• Department of Health and Social Care. (2026, April 13). NHS patients to get quicker tests and scans closer to home.
• NHS Digital. (2026, May 13). Diagnostics Waiting Times and Activity monthly collection.
• Organisation for Economic Co-operation and Development. (2025, November 13). Health at a Glance 2025: Korea.
• Organisation for Economic Co-operation and Development. (2025, November 13). Health at a Glance 2025: Japan.
• Eurostat. (2026). Healthcare resource statistics - technical resources and medical technology.
• Eurostat. (2026). Healthcare resource statistics - beds.
• DREES. (2025, December). Overview: Health expenditure in 2024.
• Cabinet Office Japan. (2025, June). Annual report on the ageing society: Summary FY2025.
• Pharmaceuticals and Medical Devices Agency. (2025, October 10). Action plan for the use of AI in operations at the PMDA.
• National Bureau of Statistics of China. (2026, February 28). Statistical communiqué of the People’s Republic of China on the 2025 national economic and social development.
• National Bureau of Statistics of China. (2025, December 31). Statistical monitoring report of outline for children’s development in China in 2024.
• Press Information Bureau. (2025, December 9). Update on Ayushman Arogya Mandirs. Ministry of Health and Family Welfare.
• Press Information Bureau. (2025, November 1). Ayushman Bharat Pradhan Mantri-Jan Arogya Yojana. National Health Authority.
• Ministry of Health and Family Welfare. (2026, January). Initiatives and achievements 2025. Government of India.
• Butterfly Network. (2024, January 8). Butterfly Network announces FDA clearance of its next-generation handheld ultrasound system, Butterfly iQ3.
• GE HealthCare. (2024, April 3). GE HealthCare introduces Caption AI on Vscan Air SL wireless handheld ultrasound system.
• Samsung. (2024, May 8). Samsung announces acquisition of Sonio to strengthen medical devices.
• Samsung Healthcare. (2024, September 3). Samsung concludes acquisition of French AI startup Sonio.
• Exo. (2025, April 2). Breakthrough AI indicator for HFpEF and cardiotoxicity added to Exo Iris.
• Butterfly Network. (2026, March 30). Butterfly Network secures first FDA clearance for blind sweep ultrasound AI tool.
• Philips. (2026, June 2). Philips receives FDA 510(k) clearance for Elevate Plus for EPIQ Elite and Affiniti.
• U.S. Food and Drug Administration. (2025, August 18). Marketing submission recommendations for a predetermined change control plan for artificial intelligence-enabled device software functions.
• GE HealthCare. (2024, July 18). GE HealthCare announces agreement to acquire clinical artificial intelligence business from Intelligent Ultrasound.
• Butterfly Network. (2025, November 17). Butterfly Network launches Compass AI to power the next generation of POCUS program management.

This bibliography is provided for reader reference and is not exhaustive. The full report contains the complete reference list and detailed citations.

This Report Answers

• Market size estimates for 2026 and forecasts through 2036 for the full-body AI ultrasound imaging market.
• Insights across more than 30 regional and country-level markets.
• Analysis of demand drivers and buyer requirements. Workflow needs and product adoption barriers are also reviewed.
• Evaluation of key technologies and modalities including AI algorithms and handheld ultrasound systems.
• Assessment of regulatory clearance and cybersecurity documentation. Clinical governance needs are also reviewed.
• Identification of growth opportunities across hospitals and clinics. Preventive health providers are also covered.
• Evaluation of supply-side dynamics and product launches. Competitive positioning is also reviewed.
• Country-level growth analysis covers India and China. The United States and South Korea are also reviewed. The United Kingdom and Japan are included. Germany and France complete the country view.
• Assessment of the competitive field including handheld ultrasound makers and enterprise imaging vendors.
• Regional outlooks cover North America and Europe. East Asia and South Asia Pacific are included. Middle East and Africa complete the regional view.
• Delivery of market data and forecasts. Supporting analysis is provided in PDF and Excel formats.